| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Protokinetix, Inc. (PKTX) has 0 insiders with recent SEC Form 4 filings, including 22 buys and 0 sells. PKTX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 11, 2016 | Smith Clarence Edward | President &CEO | Buy | 173,380 | $0.06 | $11,209.70 | +0.1% | |
| May 3, 2016 | Smith Clarence Edward | President &CEO | Buy | 416,000 | $0.06 | $26,005.10 | +0.1% | |
| Apr 28, 2016 | Smith Clarence Edward | President &CEO | Buy | 214,646 | $0.05 | $11,665.53 | +0.1% | |
| Apr 25, 2016 | Smith Clarence Edward | President &CEO | Buy | 402,631 | $0.04 | $15,255.70 | +0.2% | |
| Mar 19, 2015 | Smith Clarence Edward | President &CEO | Buy | 1,500,000 | $0.05 | $75,000.00 | +4.3% | |
| Mar 2, 2015 | Smith Clarence Edward | President &CEO | Buy | 15,000,000 | $0.03 | $375,000.00 | +76.3% |